Fuller & Thaler Asset Management
TMCI icon

Fuller & Thaler Asset Management’s Treace Medical Concepts TMCI Stock Holding History

Fuller & Thaler Asset Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68,900
Closed -$462K – 538
2025
Q3 		$462K Hold
68,900
– – ﹤0.01% 438
2025
Q2 		$405K Sell
68,900
-15,400
-18% -$100K ﹤0.01% 448
2025
Q1 		$707K Buy
84,300
+1,015
+1% +$9.12K ﹤0.01% 419
2024
Q4 		$620K Buy
83,285
+2,150
+3% +$14.4K ﹤0.01% 439
2024
Q3 		$471K Sell
81,135
-285,865
-78% -$1.84M ﹤0.01% 451
2024
Q2 		$2.44M Buy
+367,000
New +$2.96M 0.01% 357

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fuller & Thaler Asset Management's TMCI Position: Q4 2025 in Review

Fuller & Thaler Asset Management sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 68,900 shares — an estimated $462K sold.

Fuller & Thaler Asset Management first reported a position in TMCI in Q2 2024 and held it in 6 quarters. The position peaked at $2.44M in Q2 2024. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Fuller & Thaler Asset Management reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 68,900 Treace Medical Concepts shares in Q4 2025, an estimated $462K.
  • Fuller & Thaler Asset Management first reported a position in Treace Medical Concepts in Q2 2024 and held it in 6 quarters.
  • Fuller & Thaler Asset Management's Treace Medical Concepts position peaked at $2.44M in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.